These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 11191153)
1. Effects of antenatal steroids on the complications of prematurity in an era of surfactant replacement therapy in Oman. da Costa DE; Nair PA; Al Khusaiby SM J Trop Pediatr; 2000 Dec; 46(6):375-7. PubMed ID: 11191153 [TBL] [Abstract][Full Text] [Related]
2. Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation. Silver RK; Vyskocil C; Solomon SL; Ragin A; Neerhof MG; Farrell EE Obstet Gynecol; 1996 May; 87(5 Pt 1):683-91. PubMed ID: 8677067 [TBL] [Abstract][Full Text] [Related]
3. Antenatal steroid exposure and outcomes of very premature infants: a regional cohort study. Wong D; Abdel-Latif M; Kent A; Arch Dis Child Fetal Neonatal Ed; 2014 Jan; 99(1):F12-20. PubMed ID: 24142624 [TBL] [Abstract][Full Text] [Related]
4. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks' gestation. Smith LM; Qureshi N; Chao CR J Matern Fetal Med; 2000; 9(2):131-5. PubMed ID: 10902829 [TBL] [Abstract][Full Text] [Related]
5. [Prenatal steroids for fetal maturation in preterm birth. Experience at an institution]. Arroyo Cabrales LM; Guzmán Bárcenas J Ginecol Obstet Mex; 2000 Nov; 68():448-52. PubMed ID: 11195957 [TBL] [Abstract][Full Text] [Related]
6. [Can we expect decreasing the incidence of patent ductus arteriosus (PDA) in the population of premature neonates who had received antenatal steroid therapy?]. Kesiak M; Nowiczewski M; Gulczyńska E; Kasprzak E; Binikowska J; Gadzinowski J Ginekol Pol; 2005 Oct; 76(10):812-8. PubMed ID: 16417097 [TBL] [Abstract][Full Text] [Related]
7. Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone. Lee BH; Stoll BJ; McDonald SA; Higgins RD; Pediatrics; 2006 May; 117(5):1503-10. PubMed ID: 16651303 [TBL] [Abstract][Full Text] [Related]
8. The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation. Liu J; Wang Q; Zhao JH; Chen YH; Qin GL J Trop Pediatr; 2006 Oct; 52(5):355-9. PubMed ID: 16751657 [TBL] [Abstract][Full Text] [Related]
9. Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants. Farrell EE; Silver RK; Kimberlin LV; Wolf ES; Dusik JM Am J Obstet Gynecol; 1989 Sep; 161(3):628-33. PubMed ID: 2675599 [TBL] [Abstract][Full Text] [Related]
10. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Kari MA; Hallman M; Eronen M; Teramo K; Virtanen M; Koivisto M; Ikonen RS Pediatrics; 1994 May; 93(5):730-6. PubMed ID: 8165070 [TBL] [Abstract][Full Text] [Related]
11. Antenatal corticosteroids and respiratory distress syndrome - the first Polish national survey. Borszewska-Kornacka MK; Gulczyńska E; Kostuch M; Korbal P; Krajewski P; Study Group AT Ginekol Pol; 2016; 87(7):498-503. PubMed ID: 27504942 [TBL] [Abstract][Full Text] [Related]
12. [Prenatal corticotherapy and acceleration of fetal maturation. II. Results of clinical applications]. Lacaze-Masmonteil T Arch Pediatr; 1996 Nov; 3(11):1119-28. PubMed ID: 8952778 [TBL] [Abstract][Full Text] [Related]
13. Surfactant use in premature neonates <37 weeks gestation: Experience and outcome at a tertiary care hospital. Khan EA; Hashmey I J Pak Med Assoc; 2015 May; 65(5):486-90. PubMed ID: 26028381 [TBL] [Abstract][Full Text] [Related]
14. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group. Ballard RA; Ballard PL; Cnaan A; Pinto-Martin J; Davis DJ; Padbury JF; Phibbs RH; Parer JT; Hart MC; Mannino FL; Sawai SK N Engl J Med; 1998 Feb; 338(8):493-8. PubMed ID: 9468465 [TBL] [Abstract][Full Text] [Related]
15. [The effect of antenatal corticosteroid prophylaxis in premature newborns with the use of surfactant therapy]. Iarŭkova N; Nikolov A; Dimitrov A; Chernev T; Iarŭkov A Akush Ginekol (Sofiia); 1998; 37(2):20-3. PubMed ID: 9859529 [TBL] [Abstract][Full Text] [Related]
16. Short-term outcomes in low birth weight infants following antenatal exposure to betamethasone versus dexamethasone. Bar-Lev MR; Maayan-Metzger A; Matok I; Heyman Z; Sivan E; Kuint J Obstet Gynecol; 2004 Sep; 104(3):484-8. PubMed ID: 15339757 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of a single dose of antenatal corticosteroids on morbidity and mortality of preterm infants. Costa S; Zecca E; De Luca D; De Carolis MP; Romagnoli C Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):154-7. PubMed ID: 16797825 [TBL] [Abstract][Full Text] [Related]
18. Decreased respiratory compliance in infants less than or equal to 32 weeks' gestation, delivered more than 7 days after antenatal steroid therapy. McEvoy C; Schilling D; Spitale P; Peters D; O'Malley J; Durand M Pediatrics; 2008 May; 121(5):e1032-8. PubMed ID: 18450845 [TBL] [Abstract][Full Text] [Related]
19. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Spinillo A; Viazzo F; Colleoni R; Chiara A; Maria Cerbo R; Fazzi E Am J Obstet Gynecol; 2004 Jul; 191(1):217-24. PubMed ID: 15295369 [TBL] [Abstract][Full Text] [Related]
20. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome. Fujii A; Allen R; Doros G; O'Brien S J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]